Johnathan M Lancaster

Johnathan M Lancaster

UNVERIFIED PROFILE

Are you Johnathan M Lancaster?   Register this Author

Register author
Johnathan M Lancaster

Johnathan M Lancaster

Publications by authors named "Johnathan M Lancaster"

Are you Johnathan M Lancaster?   Register this Author

61Publications

1158Reads

9Profile Views

Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.

Am J Obstet Gynecol 2018 04 17;218(4):436.e1-436.e7. Epub 2018 Jan 17.

Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2018.01.015DOI Listing
April 2018

Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.

Integr Cancer Ther 2017 03 21;16(1):96-103. Epub 2016 Jul 21.

1 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1534735416660384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736072PMC
March 2017

Impact of Payer Constraints on Access to Genetic Testing.

J Oncol Pract 2017 01 23;13(1):e47-e56. Epub 2016 Oct 23.

Nashville Breast Center, Nashville, TN; Dallas Surgical Group, Dallas, TX; and Myriad Genetic Laboratories, Inc., Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013581DOI Listing
January 2017

Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health.

Patient Educ Couns 2016 10 2;99(10):1676-84. Epub 2016 May 2.

University of South Florida, Morsani College of Medicine, 12901 Bruce B. Downs Blvd. Tampa, FL 33612, United States; H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr. Tampa, FL 33612, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2016.05.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527558PMC
October 2016

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

Oncol Lett 2016 Jan 6;11(1):323-329. Epub 2015 Nov 6.

Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa Hospital and Clinics, Iowa, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.3883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726972PMC
January 2016

Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.

Int J Gynecol Cancer 2015 Nov;25(9):1724-30

*Departments of Gynecologic Oncology and †Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000549DOI Listing
November 2015

Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data.

Int J Gynecol Cancer 2015 Jul;25(6):1000-9

*Gynecologic Oncology Program, Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and †Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2015/07000/Prediction_of_O
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000449DOI Listing
July 2015

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest.

J Cancer Res Clin Oncol 2015 Feb 28;141(2):237-42. Epub 2014 Aug 28.

Department of Women's Oncology, Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1797-xDOI Listing
February 2015

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.

Gynecol Oncol 2015 Jan 17;136(1):3-7. Epub 2014 Sep 17.

The University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.09.009DOI Listing
January 2015

Metabolic vulnerabilities in endometrial cancer.

Cancer Res 2014 Oct 9;74(20):5832-45. Epub 2014 Sep 9.

Department of Pharmacology, University of Virginia, Charlottesville, Virginia. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia. Cancer Center, University of Virginia, Charlottesville, Virginia. Department of Medicine, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0254DOI Listing
October 2014

Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data.

Cancer Res 2014 Jul 21;74(14):3902-12. Epub 2014 May 21.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0186DOI Listing
July 2014

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.

Am J Obstet Gynecol 2013 Dec 9;209(6):576.e1-576.e16. Epub 2013 Aug 9.

Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2013.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840156PMC
December 2013

Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen.

Cancer Prev Res (Phila) 2013 Dec 17;6(12):1283-92. Epub 2013 Oct 17.

Suite 1507, Walgreen Building, Evanston Hospital, NorthShore University HealthSystem, 2650 Ridge Avenue, Evanston, IL 60201.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-12-0426DOI Listing
December 2013

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Authors:
Jennifer Permuth-Wey Kate Lawrenson Howard C Shen Aneliya Velkova Jonathan P Tyrer Zhihua Chen Hui-Yi Lin Y Ann Chen Ya-Yu Tsai Xiaotao Qu Susan J Ramus Rod Karevan Janet Lee Nathan Lee Melissa C Larson Katja K Aben Hoda Anton-Culver Natalia Antonenkova Antonis C Antoniou Sebastian M Armasu François Bacot Laura Baglietto Elisa V Bandera Jill Barnholtz-Sloan Matthias W Beckmann Michael J Birrer Greg Bloom Natalia Bogdanova Louise A Brinton Angela Brooks-Wilson Robert Brown Ralf Butzow Qiuyin Cai Ian Campbell Jenny Chang-Claude Stephen Chanock Georgia Chenevix-Trench Jin Q Cheng Mine S Cicek Gerhard A Coetzee Linda S Cook Fergus J Couch Daniel W Cramer Julie M Cunningham Agnieszka Dansonka-Mieszkowska Evelyn Despierre Jennifer A Doherty Thilo Dörk Andreas du Bois Matthias Dürst Douglas F Easton Diana Eccles Robert Edwards Arif B Ekici Peter A Fasching David A Fenstermacher James M Flanagan Montserrat Garcia-Closas Aleksandra Gentry-Maharaj Graham G Giles Rosalind M Glasspool Jesus Gonzalez-Bosquet Marc T Goodman Martin Gore Bohdan Górski Jacek Gronwald Per Hall Mari K Halle Philipp Harter Florian Heitz Peter Hillemanns Maureen Hoatlin Claus K Høgdall Estrid Høgdall Satoyo Hosono Anna Jakubowska Allan Jensen Heather Jim Kimberly R Kalli Beth Y Karlan Stanley B Kaye Linda E Kelemen Lambertus A Kiemeney Fumitaka Kikkawa Gottfried E Konecny Camilla Krakstad Susanne Krüger Kjaer Jolanta Kupryjanczyk Diether Lambrechts Sandrina Lambrechts Johnathan M Lancaster Nhu D Le Arto Leminen Douglas A Levine Dong Liang Boon Kiong Lim Jie Lin Jolanta Lissowska Karen H Lu Jan Lubiński Galina Lurie Leon F A G Massuger Keitaro Matsuo Valerie McGuire John R McLaughlin Usha Menon Francesmary Modugno Kirsten B Moysich Toru Nakanishi Steven A Narod Lotte Nedergaard Roberta B Ness Heli Nevanlinna Stefan Nickels Houtan Noushmehr Kunle Odunsi Sara H Olson Irene Orlow James Paul Celeste L Pearce Tanja Pejovic Liisa M Pelttari Malcolm C Pike Elizabeth M Poole Paola Raska Stefan P Renner Harvey A Risch Lorna Rodriguez-Rodriguez Mary Anne Rossing Anja Rudolph Ingo B Runnebaum Iwona K Rzepecka Helga B Salvesen Ira Schwaab Gianluca Severi Viji Shridhar Xiao-Ou Shu Yurii B Shvetsov Weiva Sieh Honglin Song Melissa C Southey Beata Spiewankiewicz Daniel Stram Rebecca Sutphen Soo-Hwang Teo Kathryn L Terry Daniel C Tessier Pamela J Thompson Shelley S Tworoger Anne M van Altena Ignace Vergote Robert A Vierkant Daniel Vincent Allison F Vitonis Shan Wang-Gohrke Rachel Palmieri Weber Nicolas Wentzensen Alice S Whittemore Elisabeth Wik Lynne R Wilkens Boris Winterhoff Yin Ling Woo Anna H Wu Yong-Bing Xiang Hannah P Yang Wei Zheng Argyrios Ziogas Famida Zulkifli Catherine M Phelan Edwin Iversen Joellen M Schildkraut Andrew Berchuck Brooke L Fridley Ellen L Goode Paul D P Pharoah Alvaro N A Monteiro Thomas A Sellers Simon A Gayther

Nat Commun 2013 ;4:1627

Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms2613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709460PMC
October 2013

Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.

Gynecol Oncol 2013 Oct 20;131(1):207-12. Epub 2013 Jul 20.

Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.07.088DOI Listing
October 2013

Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancers.

Am J Obstet Gynecol 2013 Jun 15;208(6):501.e1-7. Epub 2013 Mar 15.

Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2013.03.012DOI Listing
June 2013

The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.

Gynecol Oncol 2012 Jan 26;124(1):119-24. Epub 2011 Oct 26.

Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.09.020DOI Listing
January 2012

Microarray-based gene expression studies in ovarian cancer.

Cancer Control 2011 Jan;18(1):8-15

Department of Women's Oncology at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481101800102DOI Listing
January 2011

Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin.

Am J Obstet Gynecol 2010 Aug 4;203(2):158.e1-40. Epub 2010 May 4.

Department of Women's Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33629, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2010.02.003DOI Listing
August 2010

Gedunin, a novel natural substance, inhibits ovarian cancer cell proliferation.

Int J Gynecol Cancer 2009 Dec;19(9):1564-9

Division of Gynecologic Surgical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1111/IGC.0b013e3181a83135DOI Listing
December 2009

Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations.

J Surg Oncol 2009 Nov;100(6):511-4

Division of Gynecological Oncology, Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21372DOI Listing
November 2009

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.

Gynecol Oncol 2009 May 23;113(2):249-55. Epub 2009 Feb 23.

H Lee Moffitt Cancer Center and Research Institute, Department of Women's Oncology, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.01.014DOI Listing
May 2009

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.

Clin Cancer Res 2009 Apr 24;15(7):2448-55. Epub 2009 Mar 24.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2430DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050629PMC
April 2009

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

Gynecol Oncol 2008 Aug 21;110(2):206-15. Epub 2008 May 21.

H. Lee Moffitt Cancer Center & Research Institute, Divisions of Gynecologic Surgical Oncology, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.03.023DOI Listing
August 2008

The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy.

Am J Obstet Gynecol 2007 May;196(5):e40-2

Division of Gynecologic Surgical Oncology, Department of Interdisciplinary Oncology, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2006.10.886DOI Listing
May 2007

Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Nature 2006 Jan 6;439(7074):353-7. Epub 2005 Nov 6.

Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature04296DOI Listing
January 2006

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

Clin Cancer Res 2005 May;11(10):3686-96

Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Institute of Statistics and Decision Sciences, Center for Applied Genomics and Technology, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2398DOI Listing
May 2005

High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.

Gynecol Oncol 2005 Feb;96(2):355-61

H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, MCC-GYNPROG, Tampa, FL 33612-9497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.10.012DOI Listing
February 2005

Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays.

Am J Obstet Gynecol 2004 Apr;190(4):910-25

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2004.02.005DOI Listing
April 2004

Gene expression patterns that characterize advanced stage serous ovarian cancers.

J Soc Gynecol Investig 2004 Jan;11(1):51-9

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
January 2004

Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.

J Soc Gynecol Investig 2003 Sep;10(6):381-7

Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://rsx.sagepub.com/content/10/6/381.full.pdf
Web Search
September 2003

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Cancer Epidemiol Biomarkers Prev 2003 Mar;12(3):226-7

Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
March 2003

High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.

Clin Cancer Res 2003 Feb;9(2):762-6

Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27720, USA.

View Article

Download full-text PDF

Source
February 2003

Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.

Gynecol Oncol 2003 Jan;88(1):51-7

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
January 2003

Molecular aspects of ovarian cancer.

Best Pract Res Clin Obstet Gynaecol 2002 Aug;16(4):483-97

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
August 2002

Cell proliferation and apoptosis in human uterine leiomyomas and myometria.

Virchows Arch 2002 Jul 23;441(1):53-62. Epub 2002 Mar 23.

Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, National Institutes of health, P.O. Box 12233, MDC2-09, Research Triangle Park, NC 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-001-0568-7DOI Listing
July 2002

A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?

Gynecol Oncol 2002 Jan;84(1):36-42

Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah 84198, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/gyno.2001.6460DOI Listing
January 2002